Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

255.44
Delayed Data
As of Jul 31
 +2.98 / +1.18%
Today’s Change
141.85
Today|||52-Week Range
273.33
+36.99%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-0.05% 3 years+40.66%
3 months+22.38% 5 years+36.23%
1 year+68.62% Since inception+19.13%
Data through 07/31/2015

Quote Details

Previous close$252.46
Open day’s range251.30 – 258.82
Net asset value (NAV)252.22 (07/30/2015)
Daily volume962,924
Average volume (3 months)1,142,560
Data as of 4:00pm ET, 07/31/2015

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+36.23%+26.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.421.74
Net assets$2.7B$2.0B
Average market cap$2.2B$37.5B
Average P/E--25.5
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RDUS Radius Health Inc1.32%
KYTH KYTHERA Biopharmaceuticals Inc1.28%
ZIOP ZIOPHARM Oncology Inc1.19%
NVAX Novavax Inc1.16%
EPZM Epizyme Inc1.15%
BCRX BioCryst Pharmaceuticals Inc1.10%
PRTA Prothena Corporation PLC1.09%
RARE Ultragenyx Pharmaceutical Inc1.08%
CMRX Chimerix Inc1.06%
MDXG MiMedx Group Inc1.06%